Drug-Eluting Stent Dosing Limits Should Be Evaluated In Animals – CDRH
This article was originally published in The Gray Sheet
Executive Summary
Preclinical studies of drug-eluting stents should include overdose testing to ensure the safety of overlapping stents, FDA review staff advises